6766 Federal Register / Vol. 80, No. 25 / Friday, February 6, 2015 / Notices 

1The record is defined in sec. 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

Scoping Process 

SBMWD filed a Notice of Preparation 

(California State Clearinghouse no. 

2014111012) on November 6, 2014, 

pursuant to the California 

Environmental Quality Act (CEQA) 

(P.R.C. section 21092, C.C.R. section 

15082) and held two public scoping 

meetings on November 19, 2014. To 

avoid duplication with State and local 

procedures, we plan to use the scoping 

process initiated by SBMWD under 

CEQA. No additional public scoping 

meetings are planned at this time. The 

CEQA Notice of Preparation is available 

at http://www.usbr.gov/lc/socal/

envdocs.html. 

No known Indian trust assets or 

environmental justice issues are 

associated with the proposed action, 

although the pipeline alignments may 

include areas of low income and 

minority populations. 

Written comments are requested to 

help identify alternatives and issues that 

should be analyzed in the EIS/EIR. 

Federal, State and local agencies, tribes, 

and the general public are invited to 

participate in the environmental review 

process. 

Public Disclosure 

Before including your address, phone 

number, email address, or other 

personal identifying information in your 

comment, you should be aware that 

your entire comment—including your 

personal identifying information—may 

be made publicly available at any time. 

While you can ask us in your comment 

to withhold your personal identifying 

information from public review, we 

cannot guarantee that we will be able to 

do so. 

Dated: January 27, 2015. 

Terrance J. Fulp, 

Regional Director, Lower Colorado Region. 

[FR Doc. 2015–01942 Filed 2–5–15; 8:45 am] 

BILLING CODE 4332–90–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–1020 (Second 

Review)] 

Barium Carbonate From China 

Determination 

On the basis of the record 1 developed 

in the subject five-year review, the 

United States International Trade 

Commission (‘‘Commission’’) 

determines, pursuant to section 751(c) 

of the Tariff Act of 1930 (19 U.S.C. 

1675(c)), that revocation of the 

antidumping duty order on barium 

carbonate from China would be likely to 

lead to continuation or recurrence of 

material injury to an industry in the 

United States within a reasonably 

foreseeable time. 

Background 

The Commission instituted this 

review on February 3, 2014 (79 FR 6219) 

and determined on May 9, 2014 that it 

would conduct a full review (79 FR 

29454, May 22, 2014). Notice of the 

scheduling of the Commission’s review 

and of a public hearing to be held in 

connection therewith was given by 

posting copies of the notice in the Office 

of the Secretary, U.S. International 

Trade Commission, Washington, DC, 

and by publishing the notice in the 

Federal Register on August 1, 2014 (79 

FR 44864). The hearing was cancelled at 

the request of the domestic interested 

party. 

The Commission completed and filed 

its determination in this review on 

February 2, 2015. The views of the 

Commission are contained in USITC 

Publication 4518 (February 2015), 

entitled Barium Carbonate from China: 

Investigation No. 731–TA–1020 (Second 

Review). 

By order of the Commission. 

Issued: February 2, 2015. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2015–02341 Filed 2–5–15; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0024] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection Reports of 

Regulated Transactions Involving 

Extraordinary Quantities, Uncommon 

Methods of Payment, and Unusual/

Excessive Loss or Disappearance, and 

Regulated Transactions in Tableting/

Encapsulating Machines 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Department of Justice 

(DOJ), Drug Enforcement 

Administration (DEA), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until April 

7, 2015. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be collected 

can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other forms of 

information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Reports of Regulated Transactions 

Involving Extraordinary Quantities, 

Uncommon Methods of Payment, and 

Unusual/Excessive Loss or 

Disappearance, and Regulated 

Transactions in Tableting/Encapsulating 

Machines. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Notification of extraordinary quantities, 

uncommon methods of payment, and 

unusual/excessive loss or disappearance 

of listed chemicals and regulated 

transactions in tableting/encapsulating 

machines is provided in writing on an 

as needed basis and does not require use 

of a form. The applicable component 

within the Department of Justice is the 

Drug Enforcement Administration, 

Office of Diversion Control. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES